# Camptosar

NDC: 0009-0082
Generic name: irinotecan hydrochloride
Labeler / Manufacturer: Pharmacia & Upjohn Company LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240624

FDA application: NDA020571

## Active ingredients

- IRINOTECAN HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0009-0082"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0009-0082
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e518dfc6-7e93-4fee-a66c-51e1ab71c056